516096 SANPA

Sangal Papers Share Price

₹294.90 +12.45 (4.41%)

29 Dec, 2024 08:24

SIP TrendupStart SIP in SANPA

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month + 7.22%
  • Over 3 Month + 7.92%
  • Over 6 Month + 34.05%
  • Over 1 Year + 62.66%
SIP Lightning

Smart Investing Starts Here Start SIP with Sangal Papers for Steady Growth!

Invest Now

Sangal Papers Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Sangal Papers Financials

Sangal Papers Technicals

EMA & SMA

Current Price
₹294.90
+ 12.45 (4.41%)
pointer
  • stock-down_img
  • Bullish Moving Average 14
  • stock-up_img
  • Bearish Moving Average 2
  • 20 Day
  • ₹290.07
  • 50 Day
  • ₹280.50
  • 100 Day
  • ₹265.55
  • 200 Day
  • ₹242.45

Resistance and Support

288.32 Pivot Speed
  • R3 318.38
  • R2 307.37
  • R1 299.33
  • S1 280.28
  • S2 269.27
  • S3 261.23

What's your outlook on Sangal Papers?

You can only vote for once

Sangal Papers Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-12 Quarterly Results
2024-08-13 Quarterly Results
2024-05-30 Audited Results
2024-02-13 Quarterly Results
2023-11-09 Quarterly Results

Sangal Papers F&O

Sangal Papers Shareholding Pattern

No data available.

About Sangal Papers

  • NSE Symbol
  • SANPA
  • BSE Symbol
  • 516096
  • ISIN
  • INE384D01022

Similar Stocks to Sangal Papers

Sangal Papers FAQs

Sangal Papers share price is ₹294 As on 29 December, 2024 | 08:10

The Market Cap of Sangal Papers is ₹38.6 Cr As on 29 December, 2024 | 08:10

The P/E ratio of Sangal Papers is 9.1 As on 29 December, 2024 | 08:10

The PB ratio of Sangal Papers is 0.9 As on 29 December, 2024 | 08:10

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23